-
公开(公告)号:US11008403B2
公开(公告)日:2021-05-18
申请号:US15525821
申请日:2015-11-18
Applicant: Genentech, Inc. , Adimab LLC
Inventor: Yichin Liu , Jasvinder Atwal , Cecilia Pui Chi Chiu , Ryan J. Watts , Yan Wu , Eric Krauland , Michael Feldhaus , Yin Zhang , Joy Yu Zuchero , Jessica Couch , Mark S Dennis , James A Ernst , Gregory A Lazar
Abstract: The present invention relates to bispecific antibodies that bind to transferrin receptor and BACE1 and methods of using the same.
-
公开(公告)号:US11542308B2
公开(公告)日:2023-01-03
申请号:US17664589
申请日:2022-05-23
Applicant: Genentech, Inc.
Inventor: Yichin Liu , Christine Carine Moussion , Travis William Bainbridge , Iraj Hosseini , Gregory Alan Lazar , Sivan Cohen , Christopher Charles Kemball , Jill M. Schartner
IPC: C07K14/475 , A61K38/18 , A61K31/713 , A61K39/395 , C07K16/28 , A61K39/00
Abstract: The invention provides an effectorless immunoglobulin Fc protein, fusions of the effectorless Fc protein to a Flt3 ligand, and methods of using the same.
-
公开(公告)号:US11746160B2
公开(公告)日:2023-09-05
申请号:US17113711
申请日:2020-12-07
Applicant: Genentech, Inc. , Adimab LLC
Inventor: Yichin Liu , Jasvinder Atwal , Cecilia Pui Chi Chiu , Ryan J. Watts , Yan Wu , Eric Krauland , Michael Feldhaus
IPC: C12N15/52 , C07K16/40 , A61K47/68 , G01N33/573 , A61K39/00
CPC classification number: C07K16/40 , A61K47/6871 , C12N15/52 , C12Y304/23046 , G01N33/573 , A61K2039/505 , A61K2039/54 , A61K2039/545 , C07K2317/21 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/90 , C07K2317/92 , G01N2333/96472 , G01N2800/28 , G01N2800/52
Abstract: The invention provides antagonistic antibodies to BACE1 and methods of using the same for the treatment of neurological disease and disorders.
-
公开(公告)号:US20170362339A1
公开(公告)日:2017-12-21
申请号:US15525791
申请日:2015-11-18
Applicant: Genentech, Inc. , Adimab LLC
Inventor: Yichin Liu , Jasvinder Atwal , Cecilia Pui Chi Chiu , Ryan J. Watts , Yan WU , Eric Krauland , Michael Feldhaus
IPC: C07K16/40 , G01N33/573 , A61K47/68 , A61K39/00
CPC classification number: C07K16/40 , A61K47/6871 , A61K2039/505 , A61K2039/54 , A61K2039/545 , C07K2317/21 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/90 , C07K2317/92 , C12Y304/23046 , G01N33/573 , G01N2333/96472 , G01N2800/28 , G01N2800/52
Abstract: The invention provides antagonistic antibodies to BACE1 and methods of using the same for the treatment of neurological disease and disorders.
-
公开(公告)号:US10882920B2
公开(公告)日:2021-01-05
申请号:US15525791
申请日:2015-11-18
Applicant: Genentech, Inc. , Adimab LLC
Inventor: Yichin Liu , Jasvinder Atwal , Cecilia Pui Chi Chiu , Ryan J. Watts , Yan Wu , Eric Krauland , Michael Feldhaus
IPC: C07K16/40 , A61K47/68 , A61K39/00 , G01N33/573
Abstract: The invention provides antagonistic antibodies to BACE1 and methods of using the same for the treatment of neurological disease and disorders.
-
公开(公告)号:US20180057604A1
公开(公告)日:2018-03-01
申请号:US15525821
申请日:2015-11-18
Applicant: Genentech, Inc. , Adimab LLC
Inventor: Yichin Liu , Jasvinder Atwal , Cecilia Pui Chi Chiu , Ryan J. Watts , Yan WU , Eric Krauland , Michael Feldhaus , Yin Zhang , Joy Yu Zuchero , Jessica Couch , Mark S Dennis , James A Ernst , Gregory A Lazar
CPC classification number: C07K16/40 , A61K2039/505 , C07K16/22 , C07K16/2881 , C07K2317/21 , C07K2317/24 , C07K2317/31 , C07K2317/33 , C07K2317/41 , C07K2317/52 , C07K2317/524 , C07K2317/526 , C07K2317/528 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/71 , C07K2317/72 , C07K2317/732 , C07K2317/76 , C07K2317/90 , C07K2317/92 , C07K2317/94 , C07K2319/00 , C12Y304/23046 , G01N33/6896 , G01N2333/70582 , G01N2333/96472 , G01N2800/28 , G01N2800/52
Abstract: The present invention relates to bispecific antibodies that bind to transferrin receptor and BACE1 and methods of using the same.
-
公开(公告)号:US20210206877A1
公开(公告)日:2021-07-08
申请号:US17113711
申请日:2020-12-07
Applicant: Genentech, Inc. , Adimab LLC
Inventor: Yichin Liu , Jasvinder Atwal , Cecilia Pui Chi Chiu , Ryan J. Watts , Yan Wu , Eric Krauland , Michael Feldhaus
IPC: C07K16/40 , A61K47/68 , G01N33/573
Abstract: The invention provides antagonistic antibodies to BACE1 and methods of using the same for the treatment of neurological disease and disorders
-
-
-
-
-
-